|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's range||104.02 - 105.49|
|52-week range||93.25 - 142.60|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||23.66|
|Earnings date||24 Jan 2023 - 30 Jan 2023|
|Forward dividend & yield||1.88 (1.81%)|
|Ex-dividend date||13 Oct 2022|
|1y target est||116.38|
Abbott (ABT) closed the most recent trading day at $104.81, moving +0.91% from the previous trading session.
Heading into next year, a couple of Aristocrats that look to be good investments are Abbott Laboratories (NYSE: ABT) and ExxonMobil (NYSE: XOM). Healthcare giant Abbott Laboratories has a diverse business that generates over $1 billion in revenue every quarter from multiple segments, including medical devices, pharmaceuticals, diagnostics, and nutrition. Abbott has since restarted production and, assuming no interruptions happen again, next year should be a stronger one for that segment as well.
Disney (NYSE: DIS) is heading for a 35% decline this year. Disney has been struggling with higher costs in various areas of its business. For example, if you want to continue watching Disney+ without ads, you'll pay $3 more a month.